Bing

SEARCH HISTORY

President & CEO Leonard S Schleifer sold 45,817 shares of REGN stock on 11/12/2014 at the average price of $400.3. Hospira Inc (HSP): SVP and Special Counsel Brian J Smith sold 185,700 Shares SVP and Special Counsel Brian J Smith sold 185,700 …
Guru Focus · 11/30/2014
Pfizer (PFE)is climbing 3% in Thursday morning trading following the announcement that it will acquire Hospira (HSP ... is a 39% premium to the stock’s closing price before the deal. Pfizer has been on the prowl for an acquisition target since its ...
Barron's · ByTeresa Rivas · 2/5/2015
What’s more, let’s examine the newest info for Hospira, Inc. (NYSE:HSP). What does the ... a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300) This is a FREE report from Insider Monkey. Credit Card is NOT required.
INSIDER MONKEY · 8/26/2013
Pfizer broke the bad news in a filing on Wednesday with the Bombay Stock Exchange. It intends to close its plant ... it closes its $15 billion deal later this year to buy Hospira ($HSP). That includes a 1.1-million-square-foot, $450 million manufacturing ...
Fierce Pharma Manufacturing · 7/15/2015
It generally represents the market's view of a company's stock value and is a determining factor in stock valuation. For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25).
YCharts · 7/23/2015
Hospira, Inc. (NYSE: HSP) 34.8% HIGHER; Pfizer (NYSE: PFE) and Hospira, Inc. (NYSE: HSP) announced that they have entered into a definitive merger agreement under which Pfizer will acquire Hospira, the world’s leading provider of injectable drugs …
StreetInsider · 2/5/2015
Pfizer’s offer of $90 per share represents a premium of 39 percent to Hospira HSP stock’s close on Wednesday. The total enterprise value of the deal is about $17 billion, the companies said. “Hospira’s business aligns well with our new commercial ...
FORTUNE · 2/5/2015
... Hospira Inc. (HSP) were trading up +22.88 or +35.31 percent to $87.68 per share in Thursday's premarket after news broke early this morning that the company would be taken over by Pfizer Inc. (PFE) in a $15.2 billion deal. Hospira stock closed at $64 ...
Investor Guide · 2/5/2015
The top two positions in the S&P 500 gainers were eliminated due to pending mergers. Hospira Inc. (NYSE: HSP) was the top performing S&P 500 stock with a 43.5% gain so far this year, but Pfizer Inc. (NYSE: PFE) is acquiring Hospira for $90 per share.
24/7 Wall ST · 3/30/2015
Other practical highlights, such as the address book for up to 200 entries with three numbers each, the integrated alarm, calendar and birthday reminder functions, the baby phone with an intercom function or the brilliant HSP (High Sound Performance ...
4 Traders · 17 hours ago

Hospira

Company
Hospira, Inc. is a U.S.-based global pharmaceutical and medical device company with headquarters in Lake Forest, Illinois. It has approximat…
Hospira, Inc. is a U.S.-based global pharmaceutical and medical device company with headquarters in Lake Forest, Illinois. It has approximately 15,000 employees. Hospira is the world's largest producer of generic injectable pharmaceuticals, manufacturing generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management systems. Hospira's products are used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities. It was formerly the hospital products division of Abbott Laboratories.
Data from: Wikipedia